Literature DB >> 34001172

Percutaneous, PMMA-augmented, pedicle screw instrumentation of thoracolumbar ankylotic spine fractures.

Rina E Buxbaum1, Adi Shani2, Hani Mulla3, Alon Rod2, Nimrod Rahamimov4,5.   

Abstract

INTRODUCTION: Fractures in the ankylotic spine may have an insidious presentation but are prone to displace with devastating consequences. The long lever arm of ankylosed spine fragments may lead to pulmonary and great vessel injury and is difficult to adequately immobilize. Conservative treatment will produce in many cases poor outcomes with high morbidity and mortality. Open surgical treatment is also fraught with technical difficulties and can lead to major blood loss and prolonged operative times. In recent years, percutaneous instrumentation of non-ankylotic spine fractures has gained popularity, producing similar outcomes to open surgery with shorter operative times and reduced blood loss and hospital length of stay. We describe our experience implementing these techniques in ankylotic spine patients.
METHODS: We retrospectively retrieved from our hospital's electronic health records all patients treated for thoracolumbar spine fractures between 2008 and 2015 with a diagnosis of ankylosing spondylitis (AS) or diffuse idiopathic skeletal hyperostosis (DISH). Operative and postoperative data, results, and complications were tabulated, and radiographic parameters were evaluated.
RESULTS: Twenty-four patients with ankylotic spine disease underwent percutaneous augmented instrumentation between 2008 and 2015. The mean age was 76. All patients had at least one comorbidity. The mean number of ankylosed levels was 14. Mean operative time was 131 min. The average postoperative hemoglobin decrease was 1.21 gr/%, with only 4 patients requiring blood transfusion. 45.8% of the patients had postoperative medical complications. One patient (4.2%) had a superficial postoperative infection, and one patient died in hospital. The average hospital length of stay was 14.55 days. All patients retained their preoperative ASIA grades, and 3 improved one grade. All patients united their fractures without losing reduction.
CONCLUSIONS: PMMA-augmented percutaneous instrumentation is an attractive surgical option for this difficult patient subset, especially when compared to other available current alternatives.

Entities:  

Keywords:  Ankylosing spondylitis; DISH; Percutaneous spine surgery; Spinal cord injury; Spine trauma; Vertebral fracture

Year:  2021        PMID: 34001172     DOI: 10.1186/s13018-021-02420-7

Source DB:  PubMed          Journal:  J Orthop Surg Res        ISSN: 1749-799X            Impact factor:   2.359


  14 in total

1.  Percutaneous augmented instrumentation of unstable thoracolumbar burst fractures.

Authors:  Nimrod Rahamimov; Hani Mulla; Adi Shani; Shay Freiman
Journal:  Eur Spine J       Date:  2011-12-08       Impact factor: 3.134

2.  Percutaneous dorsal instrumentation for thoracolumbar extension-distraction fractures in patients with ankylosing spinal disorders: a case series.

Authors:  Antonio Krüger; Michael Frink; Ludwig Oberkircher; Bilal Farouk El-Zayat; Steffen Ruchholtz; Philipp Lechler
Journal:  Spine J       Date:  2014-04-24       Impact factor: 4.166

3.  The impact of a standardized "spine damage-control" protocol for unstable thoracic and lumbar spine fractures in severely injured patients: a prospective cohort study.

Authors:  Philip F Stahel; Todd VanderHeiden; Michael A Flierl; Brittany Matava; David Gerhardt; Gene Bolles; Kathryn Beauchamp; Clay Cothren Burlew; Jeffrey L Johnson; Ernest E Moore
Journal:  J Trauma Acute Care Surg       Date:  2013-02       Impact factor: 3.313

Review 4.  Percutaneous Pedicle Screw Stabilization: Surgical Technique, Fracture Reduction, and Review of Current Spine Trauma Applications.

Authors:  Dirk H Alander; Shari Cui
Journal:  J Am Acad Orthop Surg       Date:  2018-04-01       Impact factor: 3.020

5.  A Comparison of Open and Percutaneous Techniques in the Operative Fixation of Spinal Fractures Associated with Ankylosing Spinal Disorders.

Authors:  Cara L Sedney; Scott D Daffner; Abimbola Obafemi-Afolabi; Daniel Gelb; Steven Ludwig; Sanford E Emery; John C France
Journal:  Int J Spine Surg       Date:  2016-06-07

6.  Perioperative complications in open versus percutaneous treatment of spinal fractures in patients with an ankylosed spine.

Authors:  Charbel D Moussallem; Brandon A McCutcheon; Michelle J Clarke; Quanqi Cui; Bradford L Currier; Michael J Yaszemski; Paul M Huddleston; Peter S Rose; Brett Freedman; Mark B Dekutoski; Mohamad Bydon; Ahmad Nassr
Journal:  J Clin Neurosci       Date:  2016-03-30       Impact factor: 1.961

7.  Percutaneous surgery for thoraco-lumbar fractures in ankylosing spondylitis: Study of 31 patients.

Authors:  S Bredin; M Fabre-Aubrespy; B Blondel; J Falguières; S Schuller; A Walter; S Fuentes; P Tropiano; J-P Steib; Y-P Charles
Journal:  Orthop Traumatol Surg Res       Date:  2017-09-28       Impact factor: 2.256

8.  The epidemiology of osteoporosis and fractures in ankylosing spondylitis.

Authors:  Philip N Sambrook; Piet Geusens
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-08       Impact factor: 5.346

9.  Ankylosing spondylitis confers substantially increased risk of clinical spine fractures: a nationwide case-control study.

Authors:  D Prieto-Alhambra; J Muñoz-Ortego; F De Vries; D Vosse; N K Arden; P Bowness; C Cooper; A Diez-Perez; P Vestergaard
Journal:  Osteoporos Int       Date:  2014-10-24       Impact factor: 4.507

10.  Surgical Outcomes of Minimally Invasive Stabilization for Spinal Fractures in Patients with Ankylosing Spinal Disorders.

Authors:  Kazuhiro Kai; Ko Ikuta; Keigo Masuda; Takahiro Kitamura; Hideyuki Senba; Satoshi Shidahara
Journal:  Asian Spine J       Date:  2018-06-04
View more
  1 in total

1.  Percutaneous kyphoplasty for the treatment of diffuse idiopathic skeletal hyperostosis with vertebral fractures: A case report and treatment review.

Authors:  Wenhao Wang; Yixue Huang; Linlin Zhang; Huilin Yang
Journal:  Front Surg       Date:  2022-07-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.